{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:17:51Z","timestamp":1780568271315,"version":"3.54.1"},"reference-count":38,"publisher":"Baishideng Publishing Group Inc.","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.5197","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T08:06:48Z","timestamp":1221206808000},"page":"5197","source":"Crossref","is-referenced-by-count":7,"title":["Maintenance time of sedative effects after an intravenous infusion of diazepam: A guide for endoscopy using diazepam"],"prefix":"10.3748","volume":"14","author":[{"given":"Mitsushige","family":"Sugimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuhiro","family":"Ikuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingen","family":"Misaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoichi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Bell GD. Review article: premedication and intravenous sedation for upper gastrointestinal endoscopy. Aliment Pharmacol Ther 1990;4:103-122.","DOI":"10.1111\/j.1365-2036.1990.tb00455.x"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Nagengast FM. Sedation and monitoring in gastrointestinal endoscopy. Scand J Gastroenterol Suppl 1993;200:28-32.","DOI":"10.3109\/00365529309101572"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Yasumori T, Nagata K, Yang SK, Chen LS, Murayama N, Yamazoe Y, Kato R. Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 1993;3:291-301.","DOI":"10.1097\/00008571-199312000-00003"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Andersson T, Miners JO, Veronese ME, Birkett DJ. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 1994;38:131-137.","DOI":"10.1111\/j.1365-2125.1994.tb04336.x"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Andersson T, Cederberg C, Edvardsson G, Heggelund A, Lundborg P. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Clin Pharmacol Ther 1990;47:79-85.","DOI":"10.1038\/clpt.1990.12"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Ishizaki T, Chiba K, Manabe K, Koyama E, Hayashi M, Yasuda S, Horai Y, Tomono Y, Yamato C, Toyoki T. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation. Clin Pharmacol Ther 1995;58:155-164.","DOI":"10.1016\/0009-9236(95)90193-0"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Sohn DR, Kusaka M, Ishizaki T, Shin SG, Jang IJ, Shin JG, Chiba K. Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics. Clin Pharmacol Ther 1992;52:160-169.","DOI":"10.1038\/clpt.1992.125"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wan J, Xia H, He N, Lu YQ, Zhou HH. The elimination of diazepam in Chinese subjects is dependent on the mephenytoin oxidation phenotype. Br J Clin Pharmacol 1996;42:471-474.","DOI":"10.1111\/j.1365-2125.1996.tb00010.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Schmider J, Greenblatt DJ, von Moltke LL, Shader RI. Relationship of in vitro data on drug metabolism to in vivo pharmacokinetics and drug interactions: implications for diazepam disposition in humans. J Clin Psychopharmacol 1996;16:267-272.","DOI":"10.1097\/00004714-199608000-00001"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Sugimoto M, Furuta T, Shirai N, Kajimura M, Hishida A, Sakurai M, Ohashi K, Ishizaki T. Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status. Clin Pharmacol Ther 2004;76:290-301.","DOI":"10.1016\/j.clpt.2004.06.008"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Shirai N, Furuta T, Moriyama Y, Okochi H, Kobayashi K, Takashima M, Xiao F, Kosuge K, Nakagawa K, Hanai H. Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH. Aliment Pharmacol Ther 2001;15:1929-1937.","DOI":"10.1046\/j.1365-2036.2001.01108.x"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Chang M, Dahl ML, Tybring G, Gotharson E, Bertilsson L. Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. Pharmacogenetics 1995;5:358-363.","DOI":"10.1097\/00008571-199512000-00004"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Chang M, Tybring G, Dahl ML, Gotharson E, Sagar M, Seensalu R, Bertilsson L. Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19. Br J Clin Pharmacol 1995;39:511-518.","DOI":"10.1111\/j.1365-2125.1995.tb04488.x"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole. Aliment Pharmacol Ther 1999;13 Suppl 3:27-36.","DOI":"10.1046\/j.1365-2036.1999.00022.x"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Norris H. The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 1971;10:181-191.","DOI":"10.1016\/0028-3908(71)90039-6"},{"key":"ref16","unstructured":"Kosuge K, Jun Y, Watanabe H, Kimura M, Nishimoto M, Ishizaki T, Ohashi K. Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status. Drug Metab Dispos 2001;29:1284-1289."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Sundstrom I, Ashbrook D, Backstrom T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 1997;22:25-38.","DOI":"10.1016\/S0306-4530(96)00035-2"},{"key":"ref18","unstructured":"Bowden CL, Fisher JG. Relationship of diazepam serum level to antianxiety effects. J Clin Psychopharmacol 1982;2:110-114."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Dasberg HH, van der Kleijn E, Guelen JP, van Praag HM. Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect. Clin Pharmacol Ther 1974;15:473-483.","DOI":"10.1002\/cpt1974155473"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"de Morais SM, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994;46:594-598.","DOI":"10.1016\/S0026-895X(25)09788-3"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"de Morais SM, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem 1994;269:15419-15422.","DOI":"10.1016\/S0021-9258(17)40694-6"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Tauber M, Calame-Droz E, Prut L, Rudolph U, Crestani F. alpha2-gamma-Aminobutyric acid (GABA)A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo. Eur J Neurosci 2003;18:2599-2604.","DOI":"10.1046\/j.1460-9568.2003.02988.x"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"van Rijnsoever C, Tauber M, Choulli MK, Keist R, Rudolph U, Mohler H, Fritschy JM, Crestani F. Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 2004;24:6785-6790.","DOI":"10.1523\/JNEUROSCI.1067-04.2004"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Herman RJ, Wilkinson GR. Disposition of diazepam in young and elderly subjects after acute and chronic dosing. Br J Clin Pharmacol 1996;42:147-155.","DOI":"10.1046\/j.1365-2125.1996.03642.x"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Divoll M, Greenblatt DJ, Ochs HR, Shader RI. Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex. Anesth Analg 1983;62:1-8.","DOI":"10.1213\/00000539-198301000-00001"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;61:27-35.","DOI":"10.1097\/00000542-198461010-00006"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Branch RA, Morgan MH, James J, Read AE. Intravenous administration of diazepam in patients with chronic liver disease. Gut 1976;17:975-983.","DOI":"10.1136\/gut.17.12.975"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Qin XP, Xie HG, Wang W, He N, Huang SL, Xu ZH, Ou-Yang DS, Wang YJ, Zhou HH. Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects. Clin Pharmacol Ther 1999;66:642-646.","DOI":"10.1053\/cp.1999.v66.103379001"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Marks IM, Viswanathan R, Lipsedge MS, Gardner R. Enhanced relief of phobias by flooding during waning diazepam effect. Br J Psychiatry 1972;121:493-505.","DOI":"10.1192\/bjp.121.5.493"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Tansella M, Siciliani O, Burti L, Schiavon M, Zimmermann C, Gerna M, Tognoni G, Morselli PL. N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia 1975;41:81-85.","DOI":"10.1007\/BF00421061"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992;12:924-929.","DOI":"10.1523\/JNEUROSCI.12-03-00924.1992"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Veldic M, Guidotti A, Maloku E, Davis JM, Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci USA 2005;102:2152-2157.","DOI":"10.1073\/pnas.0409665102"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000;57:1061-1069.","DOI":"10.1001\/archpsyc.57.11.1061"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Woo TU, Whitehead RE, Melchitzky DS, Lewis DA. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 1998;95:5341-5346.","DOI":"10.1073\/pnas.95.9.5341"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Lewis DA, Volk DW, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl) 2004;174:143-150.","DOI":"10.1007\/s00213-003-1673-x"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, Hays AP, Dwork AJ. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000;57:349-356.","DOI":"10.1001\/archpsyc.57.4.349"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Greenblatt DJ, Abernethy DR, Morse DS, Harmatz JS, Shader RI. Clinical importance of the interaction of diazepam and cimetidine. N Engl J Med 1984;310:1639-1643.","DOI":"10.1056\/NEJM198406213102505"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Lemberger L, Rowe H, Bosomworth JC, Tenbarge JB, Bergstrom RF. The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam. Clin Pharmacol Ther 1988;43:412-419.","DOI":"10.1038\/clpt.1988.52"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i33\/5197.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:26:52Z","timestamp":1738362412000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v14\/i33\/5197.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":38,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.5197","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}